Another LNA-based RNA Inhibitor Enters Clinical Trials
... COPENHAGEN, March 20 /PRNewswire/ -- santaris
Pharma announced today that
the fourth LNA-based d...
Survivin inhibitor, which is jointly developed by santaris
Pharma and Enzon
Pharmaceuticals. The U.S. Food an...lls"
Santaris Pharma presents positive preclinical data on SPC2996 at
the American Association for Cancer Research
COPENHAGEN, 18 April 2007 - santaris
Pharma, the Danish
biopharmaceutical company devel...ts at the University of
Duisberg-Essen in Germany, santaris
researchers reported that white
blood cells obtain...tact:
Dr. Keith McCullagh
President & CEO, santaris
Tel: +45 4517 9819, Cell:+44 7939 573548...
Santaris Pharma Presents Positive Clinical Data on SPC2996 in
Chronic Lymphocytic Leukaemia
...y of Adult Leukaemia
Copenhagen, 6th June 2007 - santaris
Pharma, the Danish
biopharmaceutical company, anno...nd more common tumour type.
Dr Lene Worsaae Dalby, santaris
Pharma's Vice-President of Clinical
Development, s...ntrations. Following this second Phase
I/II study, santaris
expects to commence randomised Phase II
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
... is scheduled to commence in
Pharma's new lead candidate SPC4955 targeting
During the first half of 2009 santaris
Pharma continued to make
satisfactory progress in ...tis virus replication in the
liver. In April 2009, santaris
Pharma completed a Phase I First-in-Man single
LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
... COPENHAGEN, June 4 /PRNewswire/ -- santaris
Pharma today announced that
the cancer drug EZN-29...ha, jointly developed by
Enzon Pharmaceuticals and santaris
Pharma A/S - was well tolerated and showed
early s...edules. The
HIF-1 alpha inhibitor is licensed from santaris
The collaboration between...
Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
... COPENHAGEN, June 3 /PRNewswire/ -- santaris
Pharma and Copenhagen
Institute of Technology, Aal...enmark, announced today that
Director of microRNA, santaris
Pharma, Sakari Kauppinen, has been appointed
Adjun...Sakari Kauppinen, Director of MicroRNA Research at santaris
"I feel very honored to be app...
Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
...drugs within a short time span," said Henrik 0rum, santaris
Chief Scientific Officer.
Pharma and Enzon Pharmaceuticals signed their agreement in 2006.
As part of the agreement santaris
Pharma retains the lucrative commercial
rights to ...
LNA-Based RNA oligonucleotides Potently Inhibit Cancer microRNAs
... COPENHAGEN, April 20 /PRNewswire/ -- santaris
Pharma announced today
promising findings on the i...ated RNAs, including microRNAs," said Henrik 0rum, santaris
Scientific Officer. "These results ...rapeutics within a range of
Pharma is a leader within microRNA research and is...
Affitech Appoints Dr. Keith McCullagh as Chairman
...preneurial track record
in the biopharmaceutical industry, most recently at santaris
Denmark, where as CE0 he has played a major role in establishing ...ence industry. Most recently, from October 2003 to June 2008, he was CEO
Pharma, a Danish biopharmaceutical company. From 2000 to 2003
he was execut...
IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
...y Sector Shanghai, China GammaStar Medical Devices Group Ltd.
Hoersholm, Denmark santaris
California, USA Napo Pharmaceutical BioPharmaceutical
Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008
... COPENHAGEN, Denmark, Feb. 11 /PRNewswire/ -- santaris
Danish biopharmaceutical company devel... February
A live webcast of the santaris
Pharma presentation may be accessed from
the news ...ived and available after the presentation.
Danish Hotspot in Personalized Medicine
...ine in Denmark: Within diagnostics: Dako, Exiqon, FluimediX and Medical Prognostic
Institute. Within drug discovery: Genmab, Novo Nordisk, Pharmexa, santaris
For further information:
Vibeke Dalhoff Tel.:+45-33-26-87-22 +45-61-26-464 email: email@example.com
Gitte Pedersen tel...